Grace Therapeutics (L8S.F) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.36
-0.21
-0.06
0.09

Details

Expected EPS
-0.188386
Actual EPS
-0.17982299999999998
Surprise EPS
0.01
Surprise Percent
+4.55%

Description

Grace Therapeutics (L8S.F) has reported earnings of -0.17982299999999998 per share for Q3 2025.

0 Comments

Share your thoughts